{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T13:57:26Z","timestamp":1776347846782,"version":"3.51.2"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002713","name":"Imam Mohammed Ibn Saud Islamic University","doi-asserted-by":"publisher","award":["IMSIU-DDRSP2501"],"award-info":[{"award-number":["IMSIU-DDRSP2501"]}],"id":[{"id":"10.13039\/501100002713","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-026-03281-y","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T11:33:37Z","timestamp":1773056017000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Disrupting the USP1\u2013UAF1 deubiquitinase complex: a master regulator of replication stress and frontier target in cancer therapy"],"prefix":"10.1007","volume":"43","author":[{"given":"Emadeldin M.","family":"Kamel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally Mostafa","family":"Khadrawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed A.","family":"Allam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noha A.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faris F. Aba","family":"Alkhayl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Al Mokhtar","family":"Lamsabhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"key":"3281_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29369-3","volume":"13","author":"KE Coleman","year":"2022","unstructured":"Coleman KE, Yin Y, Lui SKL, Keegan S, Fenyo D, Smith DJ, et al. USP1-trapping lesions as a source of DNA replication stress and genomic instability. Nature Communications. 2022;13:1740. https:\/\/doi.org\/10.1038\/s41467-022-29369-3.","journal-title":"Nature Communications"},{"key":"3281_CR2","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.molcel.2005.01.008","volume":"17","author":"SM Nijman","year":"2005","unstructured":"Nijman SM, Huang TT, Dirac AM, Brummelkamp TR, Kerkhoven RM, D\u2019Andrea AD, et al. The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway. Molecular Cell. 2005;17:331\u20139. https:\/\/doi.org\/10.1016\/j.molcel.2005.01.008.","journal-title":"Molecular Cell"},{"key":"3281_CR3","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.molcel.2007.09.020","volume":"28","author":"VH Oestergaard","year":"2007","unstructured":"Oestergaard VH, Langevin F, Kuiken HJ, Pace P, Niedzwiedz W, Simpson LJ, et al. Deubiquitination of FANCD2 is required for DNA crosslink repair. Mol Cell. 2007;28:798\u2013809. https:\/\/doi.org\/10.1016\/j.molcel.2007.09.020.","journal-title":"Mol Cell"},{"key":"3281_CR4","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.molcel.2007.09.031","volume":"28","author":"MA Cohn","year":"2007","unstructured":"Cohn MA, Kowal P, Yang K, Haas W, Huang TT, Gygi SP, et al. A UAF1-containing multisubunit protein complex regulates the Fanconi anemia pathway. Mol Cell. 2007;28:786\u201397. https:\/\/doi.org\/10.1016\/j.molcel.2007.09.031.","journal-title":"Mol Cell"},{"key":"3281_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10408-5","volume":"10","author":"F Liang","year":"2019","unstructured":"Liang F, Miller AS, Longerich S, Tang C, Maranon D, Williamson EA, et al. DNA requirement in FANCD2 deubiquitination by USP1-UAF1-RAD51AP1 in the Fanconi anemia DNA damage response. Nature Communications. 2019;10:2849. https:\/\/doi.org\/10.1038\/s41467-019-10408-5.","journal-title":"Nature Communications"},{"key":"3281_CR6","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abq6353","volume":"8","author":"ML Rennie","year":"2022","unstructured":"Rennie ML, Arkinson C, Chaugule VK, Walden H. Cryo-EM reveals a mechanism of USP1 inhibition through a cryptic binding site. Sci Adv. 2022;8:eabq6353. https:\/\/doi.org\/10.1126\/sciadv.abq6353.","journal-title":"Sci Adv"},{"key":"3281_CR7","doi-asserted-by":"publisher","first-page":"3419","DOI":"10.1158\/0008-5472.Can-24-0293","volume":"84","author":"L Cadzow","year":"2024","unstructured":"Cadzow L, Brenneman J, Tobin E, Sullivan P, Nayak S, Ali JA, et al. The USP1 inhibitor KSQ-4279 overcomes PARP inhibitor resistance in homologous recombination-deficient tumors. Cancer Res. 2024;84:3419\u201334. https:\/\/doi.org\/10.1158\/0008-5472.Can-24-0293.","journal-title":"Cancer Res"},{"key":"3281_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14225539","volume":"14","author":"G Korenev","year":"2022","unstructured":"Korenev G, Yakukhnov S, Druk A, Golovina A, Chasov V, Mirgayazova R, et al. USP7 inhibitors in cancer immunotherapy: current status and perspective. Cancers. 2022;14:5539.","journal-title":"Cancers"},{"key":"3281_CR9","doi-asserted-by":"publisher","first-page":"6991","DOI":"10.1038\/s41467-025-61768-0","volume":"16","author":"N Keijzer","year":"2025","unstructured":"Keijzer N, Sakoltchik J, Majumder K, van Lil N, El Oualid F, Fish A, et al. USP1\/UAF1 targets polyubiquitinated PCNA with an exo-cleavage mechanism that can temporarily enrich for monoubiquitinated PCNA. Nat Commun. 2025;16:6991. https:\/\/doi.org\/10.1038\/s41467-025-61768-0.","journal-title":"Nat Commun"},{"key":"3281_CR10","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2315759121","volume":"121","author":"E Ryu","year":"2024","unstructured":"Ryu E, Yoo J, Kang M-S, Ha NY, Jang Y, Kim J, et al. ATAD5 functions as a regulatory platform for Ub\u2013PCNA deubiquitination. Proc Natl Acad Sci USA. 2024;121:e2315759121. https:\/\/doi.org\/10.1073\/pnas.2315759121.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3281_CR11","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.jsb.2016.09.011","volume":"196","author":"S Dharadhar","year":"2016","unstructured":"Dharadhar S, Clerici M, van Dijk WJ, Fish A, Sixma TK. A conserved two-step binding for the UAF1 regulator to the USP12 deubiquitinating enzyme. J Struct Biol. 2016;196:437\u201347. https:\/\/doi.org\/10.1016\/j.jsb.2016.09.011.","journal-title":"J Struct Biol"},{"key":"3281_CR12","doi-asserted-by":"publisher","unstructured":"Li H, Lim Kah S, Kim H, Hinds Thomas R, Jo U, Mao H, et al. Allosteric Activation of Ubiquitin-Specific Proteases by \u03b2-Propeller Proteins UAF1 and WDR20. Molecular Cell. 2016;63:249\u2009\u2013\u200960. https:\/\/doi.org\/10.1016\/j.molcel.2016.05.031.","DOI":"10.1016\/j.molcel.2016.05.031."},{"key":"3281_CR13","doi-asserted-by":"publisher","first-page":"e51749","DOI":"10.15252\/embr.202051749","volume":"22","author":"S Dharadhar","year":"2021","unstructured":"Dharadhar S, van Dijk WJ, Scheffers S, Fish A, Sixma TK. Insert L1 is a central hub for allosteric regulation of USP1 activity. EMBO Rep. 2021;22:e51749. https:\/\/doi.org\/10.15252\/embr.202051749.","journal-title":"EMBO Rep"},{"key":"3281_CR14","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1042\/bcj20230284","volume":"481","author":"BM Foster","year":"2024","unstructured":"Foster BM, Wang Z, Schmidt CK. DoUBLing up: ubiquitin and ubiquitin-like proteases in genome stability. Biochem J. 2024;481:515\u201345. https:\/\/doi.org\/10.1042\/bcj20230284.","journal-title":"Biochem J"},{"key":"3281_CR15","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s42764-021-00053-y","volume":"2","author":"X Xu","year":"2021","unstructured":"Xu X, Guo R, Xu D. The emergence of a unified mechanism in the Fanconi anemia pathway. Genome Instability Disease. 2021;2:281\u201391. https:\/\/doi.org\/10.1007\/s42764-021-00053-y.","journal-title":"Genome Instability Disease"},{"key":"3281_CR16","doi-asserted-by":"publisher","first-page":"e201800162","DOI":"10.26508\/lsa.201800162","volume":"1","author":"C Arkinson","year":"2018","unstructured":"Arkinson C, Chaugule VK, Toth R, Walden H. Specificity for deubiquitination of monoubiquitinated FANCD2 is driven by the N-terminus of USP1. Life Sci Alliance. 2018;1:e201800162. https:\/\/doi.org\/10.26508\/lsa.201800162.","journal-title":"Life Sci Alliance"},{"key":"3281_CR17","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1016\/j.str.2015.08.010","volume":"23","author":"J Yin","year":"2015","unstructured":"Yin J, Schoeffler AJ, Wickliffe K, Newton K, Starovasnik MA, Dueber EC, et al. Structural insights into WD-Repeat 48 activation of Ubiquitin-Specific protease 46. Structure. 2015;23:2043\u201354. https:\/\/doi.org\/10.1016\/j.str.2015.08.010.","journal-title":"Structure"},{"key":"3281_CR18","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.molcel.2016.05.031","volume":"63","author":"H Li","year":"2016","unstructured":"Li H, Lim KS, Kim H, Hinds TR, Jo U, Mao H, et al. Allosteric activation of Ubiquitin-Specific proteases by \u03b2-Propeller proteins UAF1 and WDR20. Mol Cell. 2016;63:249\u201360. https:\/\/doi.org\/10.1016\/j.molcel.2016.05.031.","journal-title":"Mol Cell"},{"key":"3281_CR19","doi-asserted-by":"publisher","unstructured":"Rennie ML, Arkinson C, Chaugule VK, Toth R, Walden H. Structural basis of FANCD2 deubiquitination by USP1-UAF1. bioRxiv. 2020:2020.12.05.412924. https:\/\/doi.org\/10.1101\/2020.12.05.412924.","DOI":"10.1101\/2020.12.05.412924"},{"key":"3281_CR20","doi-asserted-by":"publisher","first-page":"4546","DOI":"10.3390\/ijms22094546","volume":"22","author":"S Chen","year":"2021","unstructured":"Chen S, Liu Y, Zhou H. Advances in the development Ubiquitin-Specific peptidase (USP) inhibitors. Int J Mol Sci. 2021;22:4546. https:\/\/www.mdpi.com\/1422-0067\/22\/9\/4546.","journal-title":"Int J Mol Sci"},{"key":"3281_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02005-y","volume":"23","author":"H Gao","year":"2024","unstructured":"Gao H, Xi Z, Dai J, Xue J, Guan X, Zhao L, et al. Drug resistance mechanisms and treatment strategies mediated by Ubiquitin-Specific Proteases (USPs) in cancers: new directions and therapeutic options. Mol Cancer. 2024;23:88. https:\/\/doi.org\/10.1186\/s12943-024-02005-y.","journal-title":"Mol Cancer"},{"key":"3281_CR22","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41421-019-0102-1","volume":"5","author":"H Zhu","year":"2019","unstructured":"Zhu H, Zhang T, Wang F, Yang J, Ding J. Structural insights into the activation of USP46 by WDR48 and WDR20. Cell Discov. 2019;5:34. https:\/\/doi.org\/10.1038\/s41421-019-0102-1.","journal-title":"Cell Discov"},{"key":"3281_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-55005-3","volume":"15","author":"Y Kim","year":"2024","unstructured":"Kim Y, Ha NY, Kang MS, Ryu E, Yi G, Yoo J, et al. ATAD5-BAZ1B interaction modulates PCNA ubiquitination during DNA repair. Nat Commun. 2024;15:10496. https:\/\/doi.org\/10.1038\/s41467-024-55005-3.","journal-title":"Nat Commun"},{"key":"3281_CR24","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1016\/j.chembiol.2011.08.014","volume":"18","author":"J Chen","year":"2011","unstructured":"Chen J, Dexheimer TS, Ai Y, Liang Q, Villamil MA, Inglese J, et al. Selective and cell-active inhibitors of the USP1\/ UAF1 deubiquitinase complex reverse cisplatin resistance in non-small cell lung cancer cells. Chem Biol. 2011;18:1390\u2013400. https:\/\/doi.org\/10.1016\/j.chembiol.2011.08.014.","journal-title":"Chem Biol"},{"key":"3281_CR25","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1158\/1535-7163.Mct-13-0103-t","volume":"12","author":"H Mistry","year":"2013","unstructured":"Mistry H, Hsieh G, Buhrlage SJ, Huang M, Park E, Cuny GD, et al. Small-molecule inhibitors of USP1 target ID1 degradation in leukemic cells. Mol Cancer Ther. 2013;12:2651\u201362. https:\/\/doi.org\/10.1158\/1535-7163.Mct-13-0103-t.","journal-title":"Mol Cancer Ther"},{"key":"3281_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2025.108865","volume":"271","author":"C Torrado","year":"2025","unstructured":"Torrado C, Ashton NW, D\u2019Andrea AD, Yap TA. USP1 inhibition: a journey from target discovery to clinical translation. Pharmacol Ther. 2025;271:108865. https:\/\/doi.org\/10.1016\/j.pharmthera.2025.108865.","journal-title":"Pharmacol Ther"},{"key":"3281_CR27","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1200\/JCO.2024.42.16_suppl.3005","volume":"42","author":"TA Yap","year":"2024","unstructured":"Yap TA, Lakhani NJ, Patnaik A, Lee EK, Gutierrez M, Moore KN, et al. First-in-human phase I trial of the oral first-in-class ubiquitin specific peptidase 1 (USP1) inhibitor KSQ-4279 (KSQi), given as single agent (SA) and in combination with Olaparib (OLA) or carboplatin (CARBO) in patients (pts) with advanced solid tumors, enriched for deleterious homologous recombination repair (HRR) mutations. J Clin Oncol. 2024;42:3005. https:\/\/doi.org\/10.1200\/JCO.2024.42.16_suppl.3005.","journal-title":"J Clin Oncol"},{"key":"3281_CR28","doi-asserted-by":"publisher","first-page":"S52","DOI":"10.1016\/S0959-8049(20)31215-6","volume":"138","author":"L Cadzow","year":"2020","unstructured":"Cadzow L, Brenneman J, Sullivan P, Liu H, Shenker S, McGuire M, et al. Development of KSQ-4279 as a first-in-class USP1 inhibitor for the treatment of BRCA-deficient cancers. Eur J Cancer. 2020;138:S52. https:\/\/doi.org\/10.1016\/S0959-8049(20)31215-6.","journal-title":"Eur J Cancer"},{"key":"3281_CR29","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nchembio.1455","volume":"10","author":"Q Liang","year":"2014","unstructured":"Liang Q, Dexheimer TS, Zhang P, Rosenthal AS, Villamil MA, You C, et al. A selective USP1-UAF1 inhibitor links deubiquitination to DNA damage responses. Nat Chem Biol. 2014;10:298\u2013304. https:\/\/doi.org\/10.1038\/nchembio.1455.","journal-title":"Nat Chem Biol"},{"key":"3281_CR30","doi-asserted-by":"publisher","first-page":"15557","DOI":"10.1021\/acs.jmedchem.4c01184","volume":"67","author":"ML Rennie","year":"2024","unstructured":"Rennie ML, Gundogdu M, Arkinson C, Liness S, Frame S, Walden H. Structural and biochemical insights into the mechanism of action of the clinical USP1 inhibitor, KSQ-4279. J Med Chem. 2024;67:15557\u201368. https:\/\/doi.org\/10.1021\/acs.jmedchem.4c01184.","journal-title":"J Med Chem"},{"key":"3281_CR31","doi-asserted-by":"publisher","first-page":"4968","DOI":"10.1158\/1538-7445.Am2023-4968","volume":"83","author":"A Simoneau","year":"2023","unstructured":"Simoneau A, Wu H-J, Bandi M, Lazarides K, Sun S, Liu S, et al. Abstract 4968: characterization of the clinical development candidate TNG348 as a potent and selective inhibitor of USP1 for the treatment of BRCA1\/2mut cancers. Cancer Res. 2023;83:4968. https:\/\/doi.org\/10.1158\/1538-7445.Am2023-4968.","journal-title":"Cancer Res"},{"key":"3281_CR32","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.Targ-23-b054","volume":"22","author":"A Simoneau","year":"2023","unstructured":"Simoneau A, Pratt C, Comer G, Wu H-J, Choi A, Khendu T, et al. Abstract B054: TNG348, a selective USP1 inhibitor, shows strong preclinical combination activity with PARP inhibitors and other agents targeting DNA repair. Mol Cancer Ther. 2023;22:B054-B. https:\/\/doi.org\/10.1158\/1535-7163.Targ-23-b054.","journal-title":"Mol Cancer Ther"},{"key":"3281_CR33","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1158\/1535-7163.Mct-24-0515","volume":"24","author":"A Simoneau","year":"2025","unstructured":"Simoneau A, Pratt CB, Wu H-J, Rajeswaran SS, Comer CG, Sudsakorn S, et al. Characterization of TNG348: a selective, allosteric USP1 inhibitor that synergizes with PARP inhibitors in tumors with homologous recombination deficiency. Mol Cancer Ther. 2025;24:678\u201391. https:\/\/doi.org\/10.1158\/1535-7163.Mct-24-0515.","journal-title":"Mol Cancer Ther"},{"key":"3281_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2023.100548","volume":"18","author":"K Shang","year":"2023","unstructured":"Shang K, Zhang L, Yu Y, Xiao H, Gao Y, Yang L, et al. Disulfide-containing polymer delivery of C527 and a Platinum(IV) prodrug selectively inhibited protein ubiquitination and tumor growth on cisplatin resistant and patient-derived liver cancer models. Mater Today Bio. 2023;18:100548. https:\/\/doi.org\/10.1016\/j.mtbio.2023.100548.","journal-title":"Mater Today Bio"},{"key":"3281_CR35","doi-asserted-by":"publisher","first-page":"9657","DOI":"10.18632\/oncotarget.3922","volume":"6","author":"UL McClurg","year":"2015","unstructured":"McClurg UL, Robson CN. Deubiquitinating enzymes as oncotargets. Oncotarget. 2015;6:9657\u201368. https:\/\/doi.org\/10.18632\/oncotarget.3922.","journal-title":"Oncotarget"},{"key":"3281_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-015-0311-7","volume":"14","author":"A Olazabal-Herrero","year":"2015","unstructured":"Olazabal-Herrero A, Garc\u00eda-Santisteban I, Rodr\u00edguez JA. Structure-function analysis of USP1: insights into the role of Ser313 phosphorylation site and the effect of cancer-associated mutations on autocleavage. Mol Cancer. 2015;14:33. https:\/\/doi.org\/10.1186\/s12943-015-0311-7.","journal-title":"Mol Cancer"},{"key":"3281_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115828","author":"J Zhang","year":"2025","unstructured":"Zhang J, Rivera KD, Bossi D, Gianfanti F, Nicastri S, Gomes D, et al. An integrated proteomic portrait of prostate cancer progression. Cell Rep. 2025. https:\/\/doi.org\/10.1016\/j.celrep.2025.115828.","journal-title":"Cell Rep"},{"key":"3281_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0038570","volume":"7","author":"I Garcia-Santisteban","year":"2012","unstructured":"Garcia-Santisteban I, Zorroza K, Rodriguez JA. Two nuclear localization signals in USP1 mediate nuclear import of the USP1\/UAF1 complex. PLoS One. 2012;7:e38570. https:\/\/doi.org\/10.1371\/journal.pone.0038570.","journal-title":"PLoS One"},{"key":"3281_CR39","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrd1343","volume":"3","author":"MR Arkin","year":"2004","unstructured":"Arkin MR, Wells JA. Small-molecule inhibitors of protein-protein interactions: progressing towards the dream. Nat Rev Drug Discov. 2004;3:301\u201317. https:\/\/doi.org\/10.1038\/nrd1343.","journal-title":"Nat Rev Drug Discov"},{"key":"3281_CR40","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/nature06526","volume":"450","author":"JA Wells","year":"2007","unstructured":"Wells JA, McClendon CL. Reaching for high-hanging fruit in drug discovery at protein-protein interfaces. Nature. 2007;450:1001\u20139. https:\/\/doi.org\/10.1038\/nature06526.","journal-title":"Nature"},{"key":"3281_CR41","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1042\/bcj20160619","volume":"474","author":"PG Dougherty","year":"2017","unstructured":"Dougherty PG, Qian Z, Pei D. Macrocycles as protein-protein interaction inhibitors. Biochem J. 2017;474:1109\u201325. https:\/\/doi.org\/10.1042\/bcj20160619.","journal-title":"Biochem J"},{"key":"3281_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.109456","volume":"27","author":"Z Wang","year":"2024","unstructured":"Wang Z, Li T, Liu D, Li M, Liu S, Yu X, et al. The deubiquitinase cofactor UAF1 interacts with USP1 and plays an essential role in spermiogenesis. iScience. 2024;27:109456. https:\/\/doi.org\/10.1016\/j.isci.2024.109456.","journal-title":"iScience"},{"key":"3281_CR43","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1158\/1535-7163.Mct-22-0409","volume":"22","author":"A Simoneau","year":"2023","unstructured":"Simoneau A, Engel JL, Bandi M, Lazarides K, Liu S, Meier SR, et al. Ubiquitinated PCNA Drives USP1 Synthetic Lethality in Cancer. Molecular Cancer Therapeutics. 2023;22:215\u201326. https:\/\/doi.org\/10.1158\/1535-7163.Mct-22-0409.","journal-title":"Molecular Cancer Therapeutics"},{"key":"3281_CR44","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1038\/s41388-025-03428-7","volume":"44","author":"J Liu","year":"2025","unstructured":"Liu J, Zhang S, Cao L, Zhang N, Guo Q, Zou Y, et al. The deubiquitination-PARylation positive feedback loop of the USP10-PARP1 axis promotes DNA damage repair and affects therapeutic efficacy of PARP1 inhibitor. Oncogene. 2025;44:2515\u201329. https:\/\/doi.org\/10.1038\/s41388-025-03428-7.","journal-title":"Oncogene"},{"key":"3281_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26167709","volume":"26","author":"M Kciuk","year":"2025","unstructured":"Kciuk M, Gruszka R, Aleksandrowicz M, \u015aliwi\u0144ska A, Kontek R. ATR-CHK1 axis inhibitors in gastric cancer treatment. Int J Mol Sci. 2025;26:7709.","journal-title":"Int J Mol Sci"},{"key":"3281_CR46","doi-asserted-by":"publisher","first-page":"639","DOI":"10.21873\/cdp.10266","volume":"3","author":"M Fragkos","year":"2023","unstructured":"Fragkos M, Choleza M, Papadopoulou P. The role of \u03b3H2AX in replication Stress-induced carcinogenesis: possible links and recent developments. Cancer Diagn Progn. 2023;3:639\u201348. https:\/\/doi.org\/10.21873\/cdp.10266.","journal-title":"Cancer Diagn Progn"},{"key":"3281_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.105588","volume":"300","author":"Y Kawasoe","year":"2024","unstructured":"Kawasoe Y, Shimokawa S, Gillespie PJ, Blow JJ, Tsurimoto T, Takahashi TS. The Atad5 RFC-like complex is the major unloader of proliferating cell nuclear antigen in Xenopus egg extracts. J Biol Chem. 2024;300:105588. https:\/\/doi.org\/10.1016\/j.jbc.2023.105588.","journal-title":"J Biol Chem"},{"key":"3281_CR48","doi-asserted-by":"publisher","first-page":"5343","DOI":"10.1074\/jbc.M808430200","volume":"284","author":"MA Cohn","year":"2009","unstructured":"Cohn MA, Kee Y, Haas W, Gygi SP, D\u2019Andrea AD. UAF1 is a subunit of multiple deubiquitinating enzyme complexes. J Biol Chem. 2009;284:5343\u201351. https:\/\/doi.org\/10.1074\/jbc.M808430200.","journal-title":"J Biol Chem"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03281-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03281-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03281-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T13:07:03Z","timestamp":1776344823000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-026-03281-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":48,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["3281"],"URL":"https:\/\/doi.org\/10.1007\/s12032-026-03281-y","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]},"assertion":[{"value":"13 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Authors declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not Applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not Applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not Applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"170"}}